KRISTEN DONOHUE-GONZALEZ: Open Payments
NPI 1184999468 · STAMFORD, CT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$230 in 10 payments from 6 companies in 2025. Trend: 2023 $128 · 2024 $231 · 2025 $230
Food & beverage: $230
| Company | Payments | Amount |
|---|---|---|
| GlaxoSmithKline, LLC. | 4 | $88 |
| Organogenesis Inc. | 1 | $42 |
| Paratek Pharmaceuticals, Inc. | 2 | $33 |
| AstraZeneca Pharmaceuticals LP | 1 | $24 |
| Verona Pharma, Inc. | 1 | $22 |
| Intra-Sana Laboratories | 1 | $21 |
Products named: TRELEGY ELLIPTA, VIA MATRIX, NUZYRA, FASENRA, Ohtuvayre, NUCALA, RELTONE 200 MG.
Industry payments across CT — which companies pay providers there.
